A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to argenx
Related studies linked through entity extraction aliases.
A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Assess the Safety of ARGX-124 in Healthy Volunteers
- Status
- RECRUITING
- Phase
- PHASE1
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Status
- RECRUITING
- Phase
- PHASE2
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Status
- RECRUITING
- Phase
- PHASE2
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
- Status
- RECRUITING
- Phase
- N/A
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Status
- RECRUITING
- Phase
- PHASE3
Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess the Safety of ARGX-213 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
- Status
- RECRUITING
- Phase
- PHASE4
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Assess the Safety of ARGX-109 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4